全文获取类型
收费全文 | 7816篇 |
免费 | 439篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 91篇 |
儿科学 | 185篇 |
妇产科学 | 168篇 |
基础医学 | 1356篇 |
口腔科学 | 85篇 |
临床医学 | 675篇 |
内科学 | 1559篇 |
皮肤病学 | 224篇 |
神经病学 | 744篇 |
特种医学 | 267篇 |
外科学 | 929篇 |
综合类 | 66篇 |
预防医学 | 720篇 |
眼科学 | 172篇 |
药学 | 574篇 |
中国医学 | 8篇 |
肿瘤学 | 460篇 |
出版年
2023年 | 48篇 |
2022年 | 135篇 |
2021年 | 189篇 |
2020年 | 106篇 |
2019年 | 137篇 |
2018年 | 153篇 |
2017年 | 133篇 |
2016年 | 150篇 |
2015年 | 182篇 |
2014年 | 223篇 |
2013年 | 311篇 |
2012年 | 460篇 |
2011年 | 486篇 |
2010年 | 302篇 |
2009年 | 226篇 |
2008年 | 396篇 |
2007年 | 384篇 |
2006年 | 360篇 |
2005年 | 389篇 |
2004年 | 337篇 |
2003年 | 277篇 |
2002年 | 258篇 |
2001年 | 205篇 |
2000年 | 151篇 |
1999年 | 144篇 |
1998年 | 75篇 |
1997年 | 52篇 |
1996年 | 41篇 |
1995年 | 44篇 |
1994年 | 41篇 |
1992年 | 124篇 |
1991年 | 117篇 |
1990年 | 122篇 |
1989年 | 92篇 |
1988年 | 107篇 |
1987年 | 85篇 |
1986年 | 94篇 |
1985年 | 91篇 |
1984年 | 78篇 |
1983年 | 59篇 |
1980年 | 40篇 |
1979年 | 72篇 |
1978年 | 46篇 |
1977年 | 43篇 |
1975年 | 45篇 |
1974年 | 60篇 |
1973年 | 57篇 |
1972年 | 54篇 |
1971年 | 57篇 |
1970年 | 46篇 |
排序方式: 共有8283条查询结果,搜索用时 0 毫秒
1.
2.
Mario von Depka Murtada Hassan Jan Blatn? Petr Smejkal Vladimir Vdovin 《Blood coagulation & fibrinolysis》2006,17(4):311-316
Spontaneous and surgery-associated bleeding in patients with von Willebrand disease (vWD) cannot always be controlled with desmopressin or replacement therapy. This paper presents results on the use of recombinant-activated factor VII (rFVIIa) in patients with vWD included in the internet registry Haemostasis.com. Twenty-eight reports on the use of rFVIIa in vWD were identified from the database and included in this analysis. The bleeding episodes were classified as mild (n = 7), moderate (n = 16), or severe (n = 2), and were unspecified in three cases. The median dose of rFVIIa administered was 94 microg/kg body weight (40-127.3 microg/kg). Bleeding stopped in 23 of 27 evaluable patients (85%) and markedly decreased in three patients; the total response rate was 96% (26/27 patients). Response did not correlate with the type of vWD, the site or severity of the initial bleed, or the rFVIIa dose. Other replacement therapies were infrequently used, and their use was similar in the 24 h before and after rFVIIa administration. Eighteen patients also received antifibrinolytic treatment, but its impact on response was not recorded. Only one adverse event (mild fever) was observed. These cases suggest a role for rFVIIa as a safe and effective therapy for vWD. 相似文献
3.
4.
5.
6.
Jan Petr Jan Kybic Michael Bock Sven Müller Václav Hlavác 《Magnetic resonance in medicine》2007,58(3):582-591
A new reconstruction method for parallel MRI called PROBER is proposed. The method PROBER works in an image domain similar to methods based on Sensitivity Encoding (SENSE). However, unlike SENSE, which first estimates the spatial sensitivity maps, PROBER approximates the reconstruction coefficients directly by B-splines. Also, B-spline coefficients are estimated at once in order to minimize the reconstruction error instead of estimating the reconstruction in each pixel independently (as in SENSE). This makes the method robust to noise in reference images. No presmoothing of reference images is necessary. The number of estimated parameters is reduced, which speeds up the estimation process. PROBER was tested on simulated, phantom, and in vivo data. The results are compared with commercial implementations of the algorithms SENSE and GRAPPA (Generalized Autocalibrating Partially Parallel Acquisitions) in terms of elapsed time and reconstruction quality. The experiments showed that PROBER is faster than GRAPPA and SENSE for images wider than 150x150 pixels for comparable reconstruction quality. With more basis functions, PROBER outperforms both SENSE and GRAPPA in reconstruction quality at the cost of slightly increased computational time. 相似文献
7.
8.
9.
10.